US2014294803A1PendingUtilityA1

Methods for treating headache

Assignee: ALLERGAN INCPriority: Feb 26, 2004Filed: Mar 26, 2014Published: Oct 2, 2014
Est. expiryFeb 26, 2024(expired)· nominal 20-yr term from priority
A61P 25/30A61P 25/06A61K 38/4893
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A headache can be treated more effectively by co-administration of a botulinum toxin and a triptan drug to a patient and/or the effectiveness of a triptan medication can be increased. The botulinum toxin can be botulinum toxin type A and the botulinum toxin can be administered to or to the vicinity of where a patient experiences or is predisposed to experience pain or a headache.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A method for treating a chronic headache in a patient in need thereof, the method comprising local administration by injection of a composition comprising a botulinum toxin type A, albumin and sodium chloride reconstituted in saline or water as a diluent, wherein the number of injection sites is 23 to 58, the number of muscle areas injected is 6 to 7 and the botulinum toxin type A dose is 105 to 260 units, and wherein at least the frontal/glabellar, occipitalis, temporalis, semispinalis, splenius capitis and trapezius muscles are injected.

Join the waitlist — get patent alerts

Track US2014294803A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.